Lei Chen

Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 study

Caicun Zhou, Yi‐Long Wu, Gongyan Chen et al. · The Lancet Oncology · 2011 · 4K citations

Medicine, Pathology, Bronchial Neoplasm +8

Genome remodelling in a basal-like breast cancer metastasis and xenograft

Li Ding, Matthew J. Ellis, Shunqiang Li et al. · Nature · 2010 · 1.2K citations · Full text

Lineage Plasticity, Breast Oncology, Genome Remodelling +9

Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Apatinib in Patients With Chemotherapy-Refractory Advanced or Metastatic Adenocarcinoma of the Stomach or Gastroesophageal Junction

Jin Li, Shukui Qin, Jianming Xu et al. · Journal of Clinical Oncology · 2016 · 976 citations

Induction chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: a phase 3, multicentre, randomised controlled trial

Ying Sun, Wen-Fei Li, Nian-Yong Chen et al. · The Lancet Oncology · 2016 · 929 citations

Radiation Therapy, Medicine, Advanced Nasopharyngeal Carcinoma +9

Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma

Yuan Zhang, Lei Chen, Guoqing Hu et al. · New England Journal of Medicine · 2019 · 889 citations · Full text